1. Market Research
  2. > Pharmaceutical Market Trends
  3. > GWI Analysts' Report: Water for Pharmaceuticals

GWI Analysts' Report: Water for Pharmaceuticals

  • July 2014
  • -
  • Global Water Intelligence
  • -
  • 60 pages

Following the patent cliff in 2011, the pharmaceutical industry is in a state of flux. Blockbuster drugs which generated consistent double digit growth for Big Pharma have expired, and now the industry is turning to drastic business models to maximise their revenues. Water is a core business for the pharmaceutical industry, and these developments will ultimately have a knock-on effect on the water for pharmaceuticals market.

This GWI Analysts' Report is an essential tool for any water company working within the sector - helping you to minimise the effects that these developments have on your business and maintaining success in the industry. In 50 pages, this report will analyse the changes in market dynamics and procurement processes, helping you win bids. The report pinpoints the key areas of opportunity and growth, so you can stay ahead of the game in this changing industry.

Table Of Contents

GWI Analysts' Report: Water for Pharmaceuticals
Executive Summary. 1.1 Market Overview 2. Global Outlook 3. Technology Trends 4. Competitive Dynamics

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025 Summary Atrial fibrillation (AF) is the most common cardiac arrhythmia and is a heart condition that causes an irregula ...

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025 Summary Venous thromboembolism (VTE) is a disease that includes a myriad of life-threatening disorders ranging from ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.